Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction
Caroline Kinnear(Hospital for Sick Children), Seema Mital(University of Toronto)
Cited by 18
Related Papers
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands
|Nature Genetics|2017|945
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies
|Science|2015|905
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: Executive summary
|Canadian Journal of Cardiology|2010|201
Intrinsic Endocardial Defects Contribute to Hypoplastic Left Heart Syndrome
|Cell stem cell|2020|171